Also trades as: AVHHL (OTC) · $vol 0M
AVH.AX ASX
AVITA Medical, Inc.
1W: +6.0%
1M: +16.9%
3M: +144.4%
YTD: +214.3%
1Y: +162.7%
3Y: -28.2%
5Y: -33.0%
A$3.64 ($2.53)
+0.12 (+3.41%)
Weekly Expected Move ±8.2%
A$3
A$3
A$4
A$4
A$4
Overview
News
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$74M
+15.3% ▲
5Y CAGR: +126.1%
Gross Profit
$61M
+10.4% ▲
5Y CAGR: +159.5%
Operating Income
-$43M
+23.3% ▲
Net Income
-$50M
+18.7% ▲
EPS (Diluted)
$-0.36
+84.9% ▲
EBITDA
-$41M
+25.9% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2022 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $21M | $14M | $51M | $64M | $74M |
| YoY Growth | +0.0% | -31.0% | +0.0% | +0.0% | +15.3% |
| Cost of Revenue | $4M | $3M | $9M | $9M | $13M |
| Gross Profit | $16M | $11M | $42M | $55M | $61M |
| Gross Margin | 79.2% | 79.2% | 82.4% | 85.8% | 82.1% |
| R&D Expenses | $13M | $8M | $20M | $20M | $22M |
| SG&A Expenses | $48M | $49M | $66M | $91M | $83M |
| Operating Expenses | $77M | $54M | $81M | $112M | $104M |
| Operating Income | -$62M | -$43M | -$40M | -$57M | -$43M |
| Operating Margin | -299.2% | -299.2% | -79.9% | -88.1% | -58.6% |
| Interest Expense | $0 | $33K | $0 | $8M | $5M |
| Income Before Tax | -$61M | -$42M | -$39M | -$62M | -$50M |
| Tax Expense | $6K | $4K | $53K | $54K | $11K |
| Net Income | -$61M | -$42M | -$39M | -$62M | -$50M |
| Net Margin | -294.7% | -294.7% | -77.5% | -96.3% | -67.8% |
| EPS (Diluted) | $-0.60 | $-0.41 | $-0.31 | $-2.39 | $-0.36 |
| EBITDA | -$61M | -$42M | -$40M | -$55M | -$41M |
| Shares Outstanding | 101M | 101M | 125M | 26M | 139M |